MYC is frequently upregulated in 70–90% of both prostatic intraepithelial neoplasia (PIN) and prostate cancer lesions, and the high-level MYC expression contributes to the initiation and progression of prostate cancer [47–50]. This evidence concerns the gene MYC and prostate carcinoma.